维普期刊资源整合服务平台（V6.5）

160篇 您的检索式：作者名="Pegram M"

选中清除导出查看参考文献查看引证文献引用追踪共8页首页上一页第1页下一页末页 /8 跳转

	题名	作者	年代	出处	被引量
1	Quantitative association between HER-2/neu and steroid hormone receptors in hormone re- ceptor positive breast cancer 显示文摘	Konecny G Pauletti G Pegram M	2003	J Natal Cancer Inst2003，95，2：	1
2	Association studies of Fe~ receptor polymorphisms with outcome in HER -2 + breast cancer patients treated with trastuzumab in NCCTG (Alliance) Trial N9831 显示文摘	Norton N Olson RM Pegram M	2014	Cancer Immunol Res2014，2，10：	1
3	Correlation of drug response with the ATP tumor chemosensitivity assay in primary FIGO stage Ⅲovarian cancer显示文摘	Konecny G Crohns C Pegram M	2000	Gynecol Oncol2000，77，2：	1
4	Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer显示文摘	Konecny G Pauletti G Pegram M	2003	J Natl Cancer Inst2003，95，2：	1
5	Epidermal growth factor receptor and signal transduction: potential targets for anti-cancer therapy 显示文摘	Pal S K Pegram M	2005	Anti- cancer Drugs2005，16，5：	1
6	Combination therapy with trastuzuanrb (Hecreptin) and cispaltin for chemoresist intantmetastatci breast cancer; evidence for receptor-enhanced chemosensitive显示文摘	Pegram M D Slamon D J Dennis J S	1999	Semin Oncol1999，26，：	1
7	Biological rationale for HER2/neu(c-erbB2)as a target for monoclonal antibody therapy显示文摘	Pegram M Slamon D	2000	Semin Oncol2000，27，59：	1
8	Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers 显示文摘	Pegram M Hsu S Lewis G	1999	Oncogene1999，18，13：	1
9	Rationalcombina-tionsoftrastuzumabwithchemotherapeuticdrugsusedinthetreatmentofbreastcancer显示文摘	Pegram M KonecnyG CallaghanC etal	2004	JNatlCancerInst2004，96，：	1
10	Triple negative breast cancer:unmet medical needs 显示文摘	Pal S K Childs B H Pegram M	2011	Breast Cancer Res Treat2011，125，3：	1
11	Quantitative association between HER2/neu and steroid hormone receptors in hormone receptoe-positive primary breast cancer显示文摘	Konecny G Pauletti G Pegram M	2003	Natl Cancer Inst2003，95，2：	1
12	Phase Ⅰ study of BMS-599626,an oral pan-HER tyrosine kinase inhibitor,in patients with advanced solid tumors显示文摘	Garland LL Pegram M Song S	2005	J Clin Oncol2005，2005，23：	1
13	Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for the treatment of human breast cancers显示文摘	Hsu S Lewis G	1999	Oncogene1999，18，13：	1
14	Epidermal growth factor receptor and signal transduction:potential targets for anticancer therapy显示文摘	Kumar PS Pegram M	2005	Anticancer Drugs2005，16，5：	1
15	Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage Ⅲ ovarian cancer显示文摘	Konecny G Crohns C Pegram M	2000	Gynecol Oncol2000，77，2：	1
16	Single - agent lapatinib for HER2 - overexpressing advanced or metastatic breast cancer that progressed on first - or second - line trastuzuman-containing regimens显示文摘	BLACKWELL K L PEGRAM M D TAN CHIU E	2009	Ann Oncol2009，20，6：	1
17	Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers 显示文摘	Hsu S Lewis G	1999	Oncogene1999，18，13：	1
18	Empirical mode decomposition using rational splines:an application to rainfall time series显示文摘	Pegram G G S Peel M C McMahon T A	2008	Proceedings of the Royal Society A2008，464，3：	1
19	Empirical mode decomposition using rational splines: an application to rainfall time series显示文摘	G G S Pegram M C Peel T A McMahon	2008	Proceedings of the Royal Society A2008，464，：	1
20	HER-2/neu as a predictive marker of response to breast cancer therapy显示文摘	Pauletti G Slamon D J	1998	Breast Cancer Res Treat1998，52，：	1

返回顶部每页显示：

共8页首页上一页第1页下一页末页 /8 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示